1. Flagship
1 liveThe primary featured tool. Structured haematology interpretation and decision support.
HaemCalc
A structured digital tool for the interpretation of haematological parameters across defined clinical scenarios. Designed for educational support, with clarity, usability, and safe clinical reasoning.
2. General Haematology Interpretation
2 live · 8 proposedStructured interpretation of full blood count findings, iron and B12 metabolism, and other core general haematology investigations.
Anaemia in Pregnancy Guideline
LiveUK consultant-grade clinical guideline: trimester thresholds, ferritin interpretation, oral and IV iron pathways, postpartum bands, transfusion.
ITP in Adults Guideline
LiveConsultant-grade guideline summary for immune thrombocytopenia in adults: diagnosis of exclusion, when to treat vs observe, first-line and second-line.
Cytopenia Decision Engine
ProposedStep-by-step structured approach to investigating single and multi-lineage cytopenias.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Anaemia Pattern Interpreter
ProposedMicrocytic, normocytic, and macrocytic pattern workup with red-flag prompts.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Iron Studies Interpreter
ProposedStructured interpretation of ferritin, serum iron, TIBC, and transferrin saturation.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Macrocytosis Workup Tool
ProposedStructured workup covering B12, folate, thyroid, liver, reticulocytes, MDS flags.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Lymphocytosis Assessment Tool
ProposedBenign versus malignant lymphocytosis workup, when to send flow cytometry.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Thrombocytosis Assessment Tool
ProposedReactive vs clonal thrombocytosis, JAK2/CALR/MPL workup, referral triggers.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Eosinophilia Assessment Tool
ProposedReactive vs clonal eosinophilia, parasitic and drug aetiologies, FIP1L1-PDGFRA.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Splenomegaly Initial Assessment Tool
ProposedDifferential for palpable splenomegaly with imaging and workup checklist.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
3. Coagulation and Thrombosis
1 live · 8 proposedCoagulation screen interpretation, DOAC and warfarin management, and VTE pathway support.
Cancer-Associated Thrombosis
LiveEvidence-based guideline for cancer-associated VTE: diagnosis, anticoagulant choice, duration, Khorana risk stratification.
PT/APTT Abnormality Interpreter
ProposedStructured approach to abnormal PT and APTT, including pre-analytical and drug causes.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Mixing Study Interpreter
Proposed50:50 mixing study logic, correction vs inhibitor patterns, next-test logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
DOAC Bleeding and Reversal Decision Aid
ProposedDOAC-specific reversal pathway: apixaban, rivaroxaban, edoxaban, dabigatran. Andexanet, idarucizumab, PCC guidance.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Warfarin Reversal Decision Aid
ProposedINR-banded reversal: vitamin K, PCC, FFP. Pre-procedure bridging logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
DIC / Consumptive Coagulopathy Assessment
ProposedISTH DIC score, obstetric vs sepsis-driven DIC, supportive management.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
HIT 4Ts Assessment Tool
Proposed4Ts score with next-step workup and alternative anticoagulant choice.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
VTE Referral and Anticoagulation Checklist
ProposedFirst DVT/PE pathway, provoked vs unprovoked, duration and agent selection.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Peri-procedural Anticoagulation Planning
ProposedStop/restart timing for warfarin and DOACs around elective procedures, bridging logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
4. Emergency Haematology
6 proposedTime-critical haematology presentations. Every tool in this category will carry an explicit senior-review escalation instruction. Not a substitute for calling the on-call haematology consultant.
Suspected TTP / MAHA Pathway Tool
ProposedPLASMIC score, blood film request, ADAMTS13, urgent plasma exchange pathway.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
HLH Screening Tool
ProposedHLH-2004 criteria, H-score, triggers for bone marrow and IL-2R testing.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Neutropenic Sepsis Initial Management
ProposedSepsis-6 + empirical antibiotic logic, MASCC risk index, admission vs ambulatory.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Hyperviscosity / Leucostasis Risk Tool
ProposedSymptom clustering, WCC / paraprotein thresholds, urgent leukopheresis pathway.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Tumour Lysis Syndrome Risk Tool
ProposedCairo-Bishop criteria, risk-stratified prophylaxis, rasburicase indications.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Severe Bleeding Initial Support Tool
ProposedMassive haemorrhage protocol triggers, tranexamic acid, fibrinogen replacement logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
5. Malignant Haematology
1 live · 9 proposedHaematological malignancy workup, prognostic stratification, and MDT-ready summaries. Anchored to BSH, NICE TAs, IMWG, ELN, and iwCLL criteria.
CLL Guideline
LiveUnified clinical guideline covering iwCLL criteria, TP53 / IGHV risk stratification, first-line and relapsed/refractory treatment.
Myeloma CRAB / SLiM-CRAB Assessment
ProposedIMWG 2024 criteria applied to the workup and MDT submission.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Myeloma Imaging and Referral Checklist
ProposedWhole-body MRI / low-dose CT pathway and bone marrow workup logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Lymphoma MDT Summary Generator
ProposedStructured lymphoma MDT summary template: histology, stage, IPI, treatment intent.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
DLBCL IPI / CNS-IPI Tool
ProposedInternational Prognostic Index and CNS-IPI with treatment-intent guidance.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Follicular Lymphoma FLIPI Tool
ProposedFLIPI and FLIPI-2 with treatment-versus-observe indications.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Mantle Cell Lymphoma MIPI Tool
ProposedMIPI and MIPI-b risk stratification, fit vs unfit pathway.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
CML ELTS / Sokal Risk Tool
ProposedELTS and Sokal scores with first-line TKI selection pointers.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
MDS IPSS-R / IPSS-M Placeholder
ProposedLinks out to validated IWG-PM calculators until a local tool is in place.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
MPN Thrombosis Risk Tool
ProposedIPSET-thrombosis and ET/PV risk banding with cytoreductive-therapy indications.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
6. Transfusion Medicine
6 proposedTransfusion thresholds, massive haemorrhage support, reaction workup, and IV iron prescribing.
Red Cell Transfusion Threshold Tool
ProposedHb thresholds per patient group: stable, ACS, intensive care, chronic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Platelet Transfusion Threshold Tool
ProposedProphylactic vs procedural thresholds, bleeding thresholds, ABO-matched logic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Cryoprecipitate / Fibrinogen Tool
ProposedFibrinogen replacement threshold and dose guidance in bleeding contexts.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Massive Haemorrhage Haematology Checklist
ProposedHaematology side of the MHP: product ratios, TEG/ROTEM triggers, decision points.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Transfusion Reaction Initial Assessment
ProposedAcute reaction differential: AHTR, TACO, TRALI, febrile non-haemolytic, allergic.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
IV Iron Dose and Suitability Tool
ProposedGanzoni dosing, product-specific limits, anaphylaxis risk, pregnancy-specific rules.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
7. MDT and Pathway Tools
7 proposedTools for referral quality, pre-MDT preparation, and NHS cancer pathway timing. Support for MDT coordinators and clinical teams.
Haematology MDT Summary Generator
ProposedStructured MDT submission template with copy-to-clipboard output.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
28-Day Faster Diagnosis Standard Tracker
ProposedCounts working days from referral to communication of diagnosis; flags breach risk.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
62-Day Cancer Pathway Risk Tracker
Proposed2-week-wait to first treatment tracker with amber/red banding.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Referral Quality Checker
ProposedDoes this referral have the right minimum dataset for haematology workup?
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Should this be referred to haematology?
ProposedPrimary-care facing: common abnormalities and which need specialist review.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Watch-and-Wait Documentation Generator
ProposedStructured W&W letter for indolent lymphoma and CLL follow-up.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Pre-MDT Investigation Checklist
ProposedPer-condition pre-MDT investigation lists: myeloma, lymphoma, MDS, CLL.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
8. Audit and Governance
6 proposedAudit builders, incident reflection templates, and governance summary generators for local service evaluation.
Neutropenic Sepsis Audit Builder
ProposedAudit template against NICE NG51 with scoring grid and action log.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Transfusion Audit Builder
ProposedSHOT-aligned audit template for transfusion practice and reaction workup.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
DOAC Reversal Audit Builder
ProposedAudit template for DOAC-related bleeding and reversal decisions.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Cancer Pathway Delay Review Tool
ProposedStructured review template for breached 62-day cancer pathways.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Diagnostic Concordance Audit Tool
ProposedComparison of initial diagnosis vs MDT-confirmed diagnosis with RCPath alignment.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Incident Reflection / Governance Summary
ProposedStructured governance-report template for haematology incidents.
Proposed tool. Not yet clinically validated. No clinical decision-making should be based on this placeholder.
Educational use only. All tools listed here are intended for clinical decision support, not direct patient use. Local policies, senior clinical judgement, and current national guidelines take precedence. Proposed tools are placeholders only. None of the tools on this page have been formally ratified by any NHS trust governance committee.